Create a narrative

Shilpa Medicare Community

BSE:530549 Community

1 Narratives written by author
1 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

Shilpa Medicare

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Biologics Licensing Will Open New Market Opportunities With Aflibercept

Key Takeaways Strategic partnerships and exclusive supply agreements in the CDMO sector present opportunities for revenue growth through increased commercialization. New product launches, capacity expansions, and licensing high-margin biologics are key drivers for revenue growth and enhanced earnings.

₹1.19k

FV

47.0% undervalued

39.22%

Revenue growth p.a.

0

0

2

3 days ago